Arovella Therapeutics Limited
1 day chart
Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.
T&Cs apply![Get A$10 trading credit to start you off](/images/content-cards/reward_content_card.png)
About ALA
Arovella Therapeutics Limited (ALA, formerly Suda Pharmaceuticals Ltd) is a biotechnology company focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumours. Arovella's product is ALA-101. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types.
Buy Australian shares starting with ALA. Invest today with a CHESS-sponsored investing platform!
Sector
Health Care
CEO
-
Industry
Pharmaceuticals
Website
arovella.com
$174M
-11.54
-
$0.17
$0.17
$0.17
$0.19
$0.04
Announcements
Ready to start your investing journey with Stake?
Open an accountALA FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in ALA
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ALA
on Stake
Buy ALA from AU$3 brokerage
Invest in 2,500+ Aussie stocks and ETFs
CHESS-sponsored ASX trades
![Canstar award phone](/_next/image?url=%2Fimages%2Fstocks%2Fsidebar_phone_4x.png&w=3840&q=75)